Achieving patient engagement in pharmacovigilance: from high-income countries to lower and -middle-income countries with focus on Africa

George Tsey Sabblah,Katja Taxis,Mahama Duwiejua,Seth Kwaku Seaneke,Eugène van Puijenbroek,Florence van Hunsel
DOI: https://doi.org/10.1080/14740338.2024.2416916
2024-10-21
Expert Opinion on Drug Safety
Abstract:Introduction Patient engagement in pharmacovigilance (PEP) has been shown to improve information on adverse drug reactions (ADRs), which may not be found in reports from healthcare professionals. This review shows that there is paucity of information on PEP in lower-middle-income countries (LMICs), particularly Africa. It provides insights into PEP in high-income countries (HICs) compared with Africa to help identify the disparities and system challenges in Africa.
pharmacology & pharmacy
What problem does this paper attempt to address?